- •
Surgery, radiation, and chemotherapy have equivalent oncologic efficacy in elderly patients.
- •
Elderly patients are more likely to suffer from multiple comorbid conditions and decreased functional status.
- •
Comorbid conditions and decreased functional status increase the risk of treatment-induced morbidity.
- •
Using screening tools to evaluate comorbid conditions and functional status can help stratify patients, predict treatment toxicity, and guide treatment decisions.
- •
Elderly patients should be closely
Head and Neck Cancer and the Elderly Patient
Section snippets
Key points
Surgery
Surgery is a common treatment modality for head and neck cancer and is a major determinant of locoregional control and treatment-associated morbidity. Multiple studies have shown that oncologic outcomes after primary surgery are independent of age (Table 1).12, 13, 14 Four small retrospective single-institution series have compared survival outcomes for head and neck cancer patients treated with primary surgery between age groups. Three of these showed no difference in the 5-year survival rates
Radiation therapy
Radiation therapy is effective in the treatment of head and neck cancer and is used both in the definitive setting and in the adjuvant setting after surgery. Radiation can have many side effects, including mucositis with associated severe pain, xerostomia, skin reaction, fatigue, loss of taste and hypothyroidism. Chronic side effects include osteoradionecrosis, muscle fibrosis, trismus and secondary malignancy. In patients with limited functional status at baseline, these side effects can be
Chemotherapy
The National Comprehensive Cancer Network (NCCN) recommends the addition of chemotherapy to radiotherapy when used as definitive nonsurgical therapy for advanced stage tumors or postoperatively when there is histologic evidence of positive margins or extracapsular extension. There is some evidence, however, that the anticipated survival benefit of chemotherapy may not be seen in older patients. Pignon and colleagues8 performed a meta-analysis of 93 head and neck cancer clinical trials and found
Elderly screening
Selection of the appropriate therapy for head and neck cancer in an elderly patient requires a thorough understanding of their comorbidities, functional status, values, and social support network. The clinician and patient must decide whether the oncologic benefit relative to life expectancy is outweighed by the toxicity of treatment. There are numerous metrics that have been proposed to standardize this process.
The comprehensive geriatric assessment (CGA) is an in-depth evaluation to assess
Summary
Treatment of head and neck cancer in the elderly patient warrants special consideration of patient wishes, anticipated life span, acceptable morbidity, comorbidities, functional status, social support, and nutrition. There has not been shown to be a difference in efficacy of treatment for head and neck cancer in elderly patients. Elderly patients, however, typically have more comorbidities, and are more likely to experience toxicity related to treatment, particularly secondary to chemotherapy.
References (40)
- et al.
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients
Radiother Oncol
(2009) - et al.
Major surgery in elderly head and neck cancer patients: immediate and long-term surgical results and complication rates
Surg Oncol
(2004) - et al.
Optimal treatment for recurrent/metastatic head and neck cancer
Ann Oncol
(2010) Global epidemiology of oral and oropharyngeal cancer
Oral Oncol
(2009)- et al.
Head and neck cancer surgery in the elderly–does age influence the postoperative course?
Oral Oncol
(2010) - et al.
A case-control study on complications and survival in elderly patients undergoing major head and neck surgery
Am J Surg
(1994) - et al.
Head and neck surgery in the aged
Am J Surg
(1982) - et al.
Advanced patient age should not preclude the use of free-flap reconstruction for head and neck cancer
Am J Surg
(1994) - et al.
Octogenarian free flap reconstruction: complications and cost of therapy
Otolaryngol Head Neck Surg
(2002) - et al.
No age limit for radical radiotherapy in head and neck tumours
Eur J Cancer
(1996)
Radiation therapy for head and neck cancers in the elderly
Int J Radiat Oncol Biol Phys
Radiotherapy for head and neck cancer in elderly patients
Radiother Oncol
Radiotherapy for cancer patients aged 80 and older: a study of effectiveness and side effects
Int J Radiat Oncol Biol Phys
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
Lancet
Impact of age on acute toxicity induced by bio- or chemo-radiotherapy in patients with head and neck cancer
Oral Oncol
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
Lancet Oncol
Examining five- and ten-year survival in older women with breast cancer using cancer-specific geriatric assessment
Eur J Cancer
Geriatric assessment as a predictor of tolerance, quality of life, and outcomes in older patients with head and neck cancers and lung cancers receiving radiation therapy
Int J Radiat Oncol Biol Phys
Demographic portrayal and outcome analysis of head and neck cancer surgery in the elderly
Arch Otolaryngol Head Neck Surg
Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study
Crit Rev Oncol Hematol
Cited by (19)
Arguments for osteoporosis screening when free fibular flap reconstruction is being considered for head and neck patients
2020, British Journal of Oral and Maxillofacial SurgerySynthesis of novel N-vinylpyrrolidone/acrylic acid nanoparticles as drug delivery carriers of cisplatin to cancer cells
2020, Colloids and Surfaces B: BiointerfacesCitation Excerpt :Nowadays, cancer has become the second leading cause of death worldwide [1]. Head and neck squamous cell carcinomas (HNSCC) were defined as the cancer of mucosal lining along the upper aerodigestive tract, and were ranked to be one of the most common cancers found in men and elder people [2–4]. Oral cancer is the largest proportion of HNSCC cases with increasing incidence each year.
Foregoing elective neck dissection for elderly patients with oral cavity squamous cell carcinoma
2024, ANZ Journal of SurgeryGoing Off Guidelines: An NCDB Analysis of Missed Adjuvant Therapy Among Surgically Treated Oral Cavity Cancer
2023, Otolaryngology - Head and Neck Surgery (United States)
Disclosure: The authors have nothing to disclose.